1851 - 1875 of 8808 Results
Title
Year
-
OPENTitle: Bapineuzumab Alters Aβ Composition: Implications for the Amyloid Cascade Hypothesis and Anti-Amyloid ImmunotherapyJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 3Start Page: e59735End Page: e59735Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0059735Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0059735&type=printableCitation Count: 34
-
OPENTitle: Use of Florbetapir-PET for Imaging β-Amyloid PathologyJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 305Issue #: 3Start Page: 275End Page: 275Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2010.2008Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7041965Citation Count: 1029
-
OPENTitle: M1-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognitionJournal Name: NeuropsychopharmacologyPublisher: Springer Science and Business Media LLCVol: 43Issue #: 8Start Page: 1763End Page: 1771Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41386-018-0033-9Best OA location URL: https://www.nature.com/articles/s41386-018-0033-9.pdfCitation Count: 73
- Clinician versus machine: Reliability and responsiveness of motor endpoints in Parkinson's disease2014OPENTitle: Clinician versus machine: Reliability and responsiveness of motor endpoints in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 6Start Page: 590End Page: 595Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.02.022Citation Count: 147
-
OPENTitle: Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4). Part II: Challenges in hit-to-leadJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 19Issue #: 3Start Page: 962End Page: 966Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2008.11.104Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3787871Citation Count: 55
-
OPENTitle: Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structuresJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 118Issue #: 5Start Page: 795End Page: 808Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-011-0653-2Citation Count: 265
-
OPENTitle: Discovery, Characterization, and Antiparkinsonian Effect of Novel Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4Journal Name: Molecular PharmacologyPublisher: Elsevier BVVol: 74Issue #: 5Start Page: 1345End Page: 1358Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1124/mol.108.049551Best OA location URL: http://doi.org/10.1124/mol.108.049551Citation Count: 185
-
OPENTitle: Extra‐nigral pathological conditions are common in Parkinson's disease with freezing of gait: An in vivo positron emission tomography studyJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 9Start Page: 1118End Page: 1124Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25929Best OA location URL: https://hdl.handle.net/2027.42/108363Citation Count: 112
-
OPENTitle: Screening for Novel LRRK2 Inhibitors Using a High-Throughput TR-FRET Cellular Assay for LRRK2 Ser935 PhosphorylationJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 7Issue #: 8Start Page: e43580End Page: e43580Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0043580Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0043580&type=printableCitation Count: 38
-
OPENTitle: 4-amino-7-chloroquinoline derivatives for treating Parkinson’s disease: implications for drug discoveryJournal Name: Expert Opinion on Drug DiscoveryPublisher: Informa UK LimitedVol: 11Issue #: 4Start Page: 337End Page: 341Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1517/17460441.2016.1154529Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1517/17460441.2016.1154529?needAccess=trueCitation Count: 18
-
OPENTitle: Sensitivity to change and prediction of global change for the Alzheimer’s QuestionnaireJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-014-0092-zBest OA location URL: https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-014-0092-zCitation Count: 129
-
OPENTitle: Autonomic complaints in patients with restless legs syndromeJournal Name: Sleep MedicinePublisher: Elsevier BVVol: 14Issue #: 12Start Page: 1413End Page: 1416Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.sleep.2013.08.781Citation Count: 31
- LRRK2 functions as a Wnt signaling scaffold, bridging cytosolic proteins and membrane-localized LRP62012OPENTitle: LRRK2 functions as a Wnt signaling scaffold, bridging cytosolic proteins and membrane-localized LRP6Journal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 21Issue #: 22Start Page: 4966End Page: 4979Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/dds342Best OA location URL: https://academic.oup.com/hmg/article-pdf/21/22/4966/17257652/dds342.pdfCitation Count: 101
-
OPENTitle: Quinazolin-4-one Derivatives: A Novel Class of Noncompetitive NR2C/D Subunit-SelectiveN-Methyl-d-aspartate Receptor AntagonistsJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 53Issue #: 15Start Page: 5476End Page: 5490Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jm100027pCitation Count: 84
-
OPENTitle: Discovery, Synthesis, and Structure–Activity Relationship Development of a Series of N-4-(2,5-Dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): Characterization of a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4) with Oral Efficacy in an Antiparkinsonian Animal ModelJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 54Issue #: 21Start Page: 7639End Page: 7647Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/jm200956qCitation Count: 59
-
OPENTitle: Characterization of TAE684 as a potent LRRK2 kinase inhibitorJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 22Issue #: 5Start Page: 1864End Page: 1869Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2012.01.084Best OA location URL: http://hdl.handle.net/10871/35667Citation Count: 85
-
OPENTitle: Administration and Scoring Variance on the ADAS-CogJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 15Issue #: 3Start Page: 461End Page: 464Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-2008-15312Citation Count: 83
-
OPENTitle: Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neuronsJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 104Issue #: 4Start Page: 1325End Page: 1330Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.0605208103Best OA location URL: http://doi.org/10.1073/pnas.0605208103Citation Count: 578
-
OPENTitle: Balancing the basal ganglia circuitry: A possible new role for dopamine D2 receptors in health and diseaseJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 7Start Page: 895End Page: 903Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26282Citation Count: 47
-
OPENTitle: Synthesis and SAR of novel, 4-(phenylsulfamoyl)phenylacetamide mGlu4 positive allosteric modulators (PAMs) identified by functional high-throughput screening (HTS)Journal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 20Issue #: 17Start Page: 5175End Page: 5178Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2010.07.007Citation Count: 29
-
OPENTitle: Vitamin D Status During Pregnancy and Risk of Multiple Sclerosis in Offspring of Women in the Finnish Maternity CohortJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 73Issue #: 5Start Page: 515End Page: 515Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2015.4800Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2499458/noi150103.pdfCitation Count: 169
-
OPENTitle: Solution-Phase Parallel Synthesis and SAR of Homopiperazinyl Analogs as Positive Allosteric Modulators of mGlu4Journal Name: ACS Combinatorial SciencePublisher: American Chemical Society (ACS)Vol: 13Issue #: 2Start Page: 159End Page: 165Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/co1000508Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3057427Citation Count: 8
-
OPENTitle: Allopregnanolone Reinstates Tyrosine Hydroxylase Immunoreactive Neurons and Motor Performance in an MPTP-Lesioned Mouse Model of Parkinson's DiseaseJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 7Issue #: 11Start Page: e50040End Page: e50040Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0050040Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0050040&type=printableCitation Count: 50
-
OPENTitle: Ranbp2 haploinsufficiency mediates distinct cellular and biochemical phenotypes in brain and retinal dopaminergic and glia cells elicited by the Parkinsonian neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Journal Name: Cellular and Molecular Life SciencesPublisher: Springer Science and Business Media LLCVol: 69Issue #: 20Start Page: 3511End Page: 3527Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1007/s00018-012-1071-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00018-012-1071-9.pdfCitation Count: 33
-
OPENTitle: Remote control of induced dopaminergic neurons in parkinsonian ratsJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 124Issue #: 7Start Page: 3215End Page: 3229Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci74664Best OA location URL: http://www.jci.org/articles/view/74664/files/pdfCitation Count: 118